Search research articles
Contact Us
Filters
Showing results (71-80 of 77) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 77 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 7, 2022
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 6, 2020
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Blood
|
February 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma
Laura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.
Blood Advances
|
March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
Reid W Merryman, Robert A Redd, Taiga Nishihori, et al.
The Lancet. Healthy Longevity
|
February 21, 2022
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium
Arielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, et al.
Leukemia
|
March 4, 2021
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Reid W Merryman, Luca Castagna, Laura Giordano, et al.
Blood Cancer Discovery
|
March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 77) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 77 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 7, 2022
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 6, 2020
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Blood
|
February 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma
Laura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.
Blood Advances
|
March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
Reid W Merryman, Robert A Redd, Taiga Nishihori, et al.
The Lancet. Healthy Longevity
|
February 21, 2022
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium
Arielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, et al.
Leukemia
|
March 4, 2021
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Reid W Merryman, Luca Castagna, Laura Giordano, et al.
Blood Cancer Discovery
|
March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Page
of 8